Blood Gas and Electrolyte Analyzer Market - Growth, Trends, and Forecast (2020 - 2025)
|発行||Mordor Intelligence LLP||商品コード||921919|
|出版日||ページ情報||英文 111 Pages
|世界の血液ガスおよび電解質分析装置市場：成長、動向、および予測（2020年～2025年） Blood Gas and Electrolyte Analyzer Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日: 2020年01月01日||ページ情報: 英文 111 Pages||
The analyzers are important in the critical care units to determine the blood gas, pH, electrolytes, and some metabolites in the whole blood specimen. The technological advancement in the past decade has significantly improved the method of diagnosis and treatment in the healthcare facilities. The recent advances have enabled clinicians to direct therapy and improve patient outcomes. A large number of basic and complicated parameters are now being carried out for patients suffering from life-threatening respiratory disturbances and acid-base imbalances. For example, the epic Blood Analysis System wireless solution for testing by Alere, Inc (Abbott Laboratories) which features smartcard technology offers 11 tests from a very small sample of blood (92 µL, about 1/10th of a CC, sample). Other factors such as the growing patient population in the critical care units and government and private sectors collaboration with healthcare facilities, all drive the demand of the blood gas electrolyte analyzer. Some of the major restraining factors in the market include the cost of the analyzer, reimbursement issues, and complicated regulations.
The blood gas and electrolyte analyzers are useful medical devices for the detection of metabolic imbalances, and measurement of renal and cardiac functions. It is traditionally performed in the clinical chemistry laboratory, but, now becoming popular and common in the point-of-care testing. The scope of this market report is segmented by modality, product, and end-user, among different geographies.
Portable Blood Gas and Electrolyte Analyzers is Expected to Grow at Better Rate than Other, Over the Forecast Period
The portable devices are easy to use, handle and with minimum maintenance requirement which helps in its better adoption rate. There are several companies that are investing in the development and marketing of these products. Though there is the edge for the portable devices over the conventional devices, the concerns and challenges arise when there are being operated by the non-laboratory staff such as nurses and physicians, which sometimes restricts the extent of results being obtained. With that, in the emergency and critical care settings, it is important for the doctors/physicians and laboratorians to build upon the synergistic efforts towards using portable devices in POCT and conventional laboratory settings. With that, the positives and benefits of using such devices are more, which drives the adoption rate of these products in the market, over the forecast period.
North America is Expected to Dominate the Market Among Other Regions, over the Forecast Period
North America is expected to dominate this market in terms of revenue generation, over the forecast period. The large presence of domestic and international medical devices companies from both the developed and emerging markets boost the demand and growth of analyzes in the country. The better network between the multispecialty hospitals with the insurance companies and medical device companies drives the importance of this market in the United States. Medical tourism also attracts many patients from many countries to get better healthcare facilities in the region. The growing preference towards the point of care testing by both the companies and hospitals fuel the growth of the studied market in the region. Europe is expected to follow next by market size because of the significant presence of medical device companies and the old age population across the region.
The companies in this market have advanced in providing analyzer with display monitors to monitor the patients before electronically transferring them for permanent record within information management systems. Some of the major players active in this market include Abbott laboratories, F Hoffman La Roche Ltd, Siemens Healthineers, Medica Corporation, Danaher Corporation, among others.